chevron_leftBack
As of 6 June 2026, LanZhou Foci Pharmaceutical Co.,Ltd. has a market cap of $620.08M USD, ranking #13734 globally and #4194 in China.
It ranks #1236 in the Healthcare sector, and #69 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$620.08MUSD
4.2B CNY
Enterprise Value
$552.68MUSD
3.74B CNY
Revenue (TTM)
$135.24MUSD
915.53M CNY
EBITDA (TTM)
$18.24MUSD
123.48M CNY
Net Income (TTM)
$7.27MUSD
49.21M CNY
EBITDA Margin
13%
Profit Margin
5.4%
PE Ratio
85.3
PS Ratio
4.6
PB Ratio
2.3
EV/EBITDA
30.0
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.1% | 2.4% | -2.1% | -3.8% | -6.3% | 7.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002644
兰州佛慈制药股份有限公司 Class A
ISIN: CNE1000019W4
Shares Out.:
Shares Outstanding:
510.657M1
Shares Float:
195.943M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8.39 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About LanZhou Foci Pharmaceutical Co.,Ltd.
LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing and selling of Chinese herbal medicine pieces; and production and sales of medical devices, such as protective masks. In addition, the company exports its products. LanZhou Foci Pharmaceutical Co.,Ltd. was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
2K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
1K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
742%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
578%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
427%
22.12B CNY
|
8.1
|
|
|
$2.74B
342%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
6K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
5K%
|
-
|
|
NSE: CIPLA
|
$11.12B
2K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
2K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.79B
1K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.43B
1K%
807.02B INR
|
23.1
|
chevron_leftBack